PT  - JOURNAL ARTICLE
AU  - Mark Cherrie
AU  - Tom Clemens
AU  - Claudio Colandrea
AU  - Zhiqiang Feng
AU  - David J Webb
AU  - Chris Dibben
AU  - Richard B Weller
TI  - Ultraviolet A Radiation and COVID-19 Deaths in the USA with replication studies in England and Italy
AID  - 10.1101/2020.07.03.20145912
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.03.20145912
4099  - http://medrxiv.org/content/early/2020/12/23/2020.07.03.20145912.short
4100  - http://medrxiv.org/content/early/2020/12/23/2020.07.03.20145912.full
AB  - Seasonal variation in environmental meteorological conditions affect the incidence of infectious diseases. Ultraviolet A (UVA) radiation induces release of cutaneous photolabile nitric oxide (NO) impacting the cardiovascular system and metabolic syndrome, COVID-19 risk factors. NO also inhibits the replication of SARS-CoV. We therefore model the relationship between UVA radiation, derived from remote sensed data, and COVID-19 deaths for counties across the USA during their ‘UV vitamin D winter’ (Jan-April) adjusting for confounding including by temperature and humidity. The Mortality Risk Ratio (MRR) falls by 29% (40% -15% (95% CI)) per 100 (KJ/m2) increase in mean daily UVA. We replicate this in independent studies in Italy and England and estimate a pooled decline in MRR of 32% (48%-12%) per 100 KJ/m2 across the three studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used publicly available datasets and there was no link to individual patientsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData Availability The UVA estimates were developed by JAXA, with MODIS data provided by NASA GSFC, and available from ftp://apollo.eorc.jaxa.jp/pub/JASMES/Global_05km/. The long term UVvitd estimates were developed by NCAR and available from https://www2.acom.ucar.edu/modeling/tuv-download. The USA COVID-19 death and county level indicators of population, socioeconomic and environmental data (PM2.5 and temperature) were developed previously by Xiao Wu et al., and are available here: https://github.com/wxwx1993/PM_COVID. Code Availability The code and data to reproduce the current study is held at https://github.com/markocherrie/COVID19_UVA. ftp://apollo.eorc.jaxa.jp/pub/JASMES/Global_05km/ https://www2.acom.ucar.edu/modeling/tuv-download https://github.com/wxwx1993/PM_COVID.